HealthLeaders Media September 19, 2022
Eric Wicklund

Researchers from Stanford, USC, Georgia Tech, and the University of Tokyo have developed a battery-powered digital health wearable that attaches to the skin and can measure tumor size continuously and in real time, offering hope for advancements in both cancer research and treatment.

Researchers has developed a wearable digital health sensors that can track the size of a tumor, a vital factor in determining the effectiveness of cancer drugs.

The Flexible Autonomous Sensor measuring Tumors (FAST) device, a battery-powered patch that adheres to the skin, measures the strain on the membrane surrounding the tumor in real-time and transmits the data to a smartphone app. It has the potential to replace the traditional method of tracking tumors via caliper and bioluminescence,...

Today's Sponsors

LEK
Teladoc Health
Amwell

Today's Sponsors

LEK
Teladoc Health

Today's Sponsor

Oliver Wyman

 
Topics: Digital Health, Provider, Technology, Wearables
‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches
Another View: Wearables, Digital Health And You
Forget smartwatches, consumers are snapping up these quirky alternatives
Driving Healthcare Operational Efficiency with IoT Sensing as a Service
Five ways wearables will transform healthcare in 2023